The rapid expansion of private credit established the asset class as an alternative for portfolio diversification. However, its lack of public transaction data has historically posed valuation challenges. According to a report by the Investment Company Institute (ICI), this landscape is changing rapidly as market infrastructure matures, standardized secondary trading develops, and advanced artificial intelligence (AI) begins to automate data aggregation.
Key Takeaways:
- Technological advancements and maturing market infrastructure are bridging the traditional valuation gap in private credit by enhancing price transparency and real-time data inputs.
- The Simplify Private Credit Strategy ETF (PCR) provides liquid, transparent exposure to private credit by investing in publicly traded BDCs and closed-end funds rather than illiquid direct loans.
- To mitigate default risk while delivering high yields, PCR utilizes a systematic factor-based credit hedge alongside the operational simplicity of standard ETF tax reporting.
See More: Private Credit Sees Rise in Acceptance For DC Plan Portfolios
Bridging the Transparency Gap With Liquid Vehicles
As a result of these structural advancements, the ICI report noted that it can enhance the “range, timeliness, quantity, and quality of inputs available to support fair value determinations.” For retail investors looking to capitalize on this evolving market without the operational headwinds of opaque pricing and lock-up periods, the Simplify Private Credit Strategy ETF (PCR) is an ideal solution. The fund provides investors with access to the private credit market with the inherent benefits of an ETF such as cost-efficiency, flexibility, and transparency.
While the ICI notes that fund valuation practices for private credit are “not static” and must continuously adapt to new data sources, PCR bypasses valuation challenges by tracking the liquid VettaFi Private Credit Index. Instead of holding illiquid, non-traded loans directly, PCR invests in publicly traded Business Development Companies (BDCs) and closed-end funds (CEFs). This strategy gives prospective investors pure-play exposure to private markets while ensuring the aforementioned institutional-grade transparency and daily liquidity of an ETF.
Enhancing Performance and Mitigating Risk
As data analytics and machine learning models make it easier to identify borrower defaults and credit rating changes early, PCR introduces its own systematic layer of risk management. The ETF implements a proprietary quality-junk credit hedge based on total return swaps. This factor-based hedge takes long positions in highly capitalized firms and shorts vulnerable companies reliant on refinancing. On top of that, the fund has a distribution rate of 11.48% as of May 31, 2026.
By combining the high-income potential of private credit with institutional credit hedges and the operational ease of a standard 1099 tax form, PCR perfectly mirrors the ICI’s vision for the asset class, which is a highly governed, transparent, and modernized approach to income generation.
For more news, information, and analysis, visit the Institutional Income Strategies Content Hub.
VettaFi LLC (“VettaFi”) is the index provider for PCR, for which it receives an index licensing fee. However, PCR is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of PCR.
